Does vasopressor therapy have an indication in hemorrhagic shock?

François Beloncle, Ferhat Meziani, Nicolas Lerolle, Peter Radermacher, Pierre Asfar, François Beloncle, Ferhat Meziani, Nicolas Lerolle, Peter Radermacher, Pierre Asfar

Abstract

This review aimed to answer whether the vasopressors are useful at the early phase of hemorrhagic shock. Data were taken from published experimental studies and clinical trials. Published case reports were discarded. A search of electronic database PubMed was conducted using keywords of hemorrhagic shock, vasopressors, vasoconstrictors, norepinephrine, epinephrine, vasopressin. The redundant papers were not included. We identified 15 experimental studies that compared hemorrhagic shock resuscitated with or without vasopressors, three retrospective clinical studies, and one controlled trial. The experimental and clinical studies are discussed in the clinical context, and their strengths as well as limitations are highlighted. There is a strong rationale for a vasopressor support in severe hemorrhagic shock. However, this should be tempered by the risk of excessive vasoconstriction during such hypovolemic state. The experimental models must be analyzed within their own limits and cannot be directly translated into clinical practice. In addition, because of many biases, the results of clinical trials are debatable. Therefore, based on current information, further clinical trials comparing early vasopressor support plus fluid resuscitation versus fluid resuscitation alone are warranted.

References

    1. Fangio P, Asehnoune K, Edouard A, Smail N, Benhamou D. Early embolization and vasopressor administration for management of life-threatening hemorrhage from pelvic fracture. J Trauma. 2005;3:978–984. doi: 10.1097/01.TA.0000163435.39881.26. discussion 984.
    1. Rose B, Mandell S. In: Up to Date 172. KW, editor. Waltham, MA: UpToDate; 2009. Treatment of severe hypovolemia and hypovolemic shock in adults.
    1. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Gordini G, Stahel PF, Hunt BJ, Komadina R, Neugebauer E. Management of bleeding following major trauma: a European guideline. Crit Care. 2007;3:R17. doi: 10.1186/cc5686.
    1. Walley K, Wood L. In: Principles of critical care. Hall JB SG, Wood LD, editor. New York: McGraw-Hill; 1998. Shock; pp. 277–302.
    1. Schadt JC, Ludbrook J. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol. 1991;3:H305–H318.
    1. Vatner SF, Braunwald E. Cardiovascular control mechanisms in the conscious state. N Engl J Med. 1975;3:970–976. doi: 10.1056/NEJM197511062931906.
    1. Dalibon N, Schlumberger S, Saada M, Fischler M, Riou B. Haemodynamic assessment of hypovolaemia under general anaesthesia in pigs submitted to graded haemorrhage and retransfusion. Br J Anaesth. 1999;3:97–103. doi: 10.1093/bja/82.1.97.
    1. Barroso-Aranda J, Zweifach BW, Mathison JC, Schmid-Schonbein GW. Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock. J Cardiovasc Pharmacol. 1995;3(Suppl 2):S23–S29.
    1. Shenkar R, Coulson WF, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol. 1994;3:290–297. doi: 10.1165/ajrcmb.10.3.8117448.
    1. Douzinas EE, Livaditi O, Tasoulis MK, Prigouris P, Bakos D, Goutas N, Vlachodimitropoulos D, Andrianakis I, Betrosian A, Tsoukalas GD. Nitrosative and oxidative stresses contribute to post-ischemic liver injury following severe hemorrhagic shock: the role of hypoxemic resuscitation. PLoS One. 2012;3:e32968. doi: 10.1371/journal.pone.0032968.
    1. Thiemermann C, Szabo C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA. 1993;3:267–271. doi: 10.1073/pnas.90.1.267.
    1. Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Hollingsworth-Fridlund P, Hoyt DB. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg. 1998;3:528–533. doi: 10.1016/S1072-7515(98)00082-9.
    1. Eberhard LW, Morabito DJ, Matthay MA, Mackersie RC, Campbell AR, Marks JD, Alonso JA, Pittet JF. Initial severity of metabolic acidosis predicts the development of acute lung injury in severely traumatized patients. Crit Care Med. 2000;3:125–131. doi: 10.1097/00003246-200001000-00021.
    1. Zenati MS, Billiar TR, Townsend RN, Peitzman AB, Harbrecht BG. A brief episode of hypotension increases mortality in critically ill trauma patients. J Trauma. 2002;3:232–236. doi: 10.1097/00005373-200208000-00007.
    1. Hamzaoui O, Georger JF, Monnet X, Ksouri H, Maizel J, Richard C, Teboul JL. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care. 2010;3:R142. doi: 10.1186/cc9207.
    1. Smail N, Descorps Declere A, Duranteau J, Vigue B, Samii K. Left ventricular function after severe trauma. Intensive Care Med. 1996;3:439–442. doi: 10.1007/BF01712161.
    1. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;3:656–665. doi: 10.1056/NEJMra0910283.
    1. Nouira S, Elatrous S, Dimassi S, Besbes L, Boukef R, Mohamed B, Abroug F. Effects of norepinephrine on static and dynamic preload indicators in experimental hemorrhagic shock. Crit Care Med. 2005;3:2339–2343. doi: 10.1097/01.CCM.0000182801.48137.13.
    1. Hinder F, Stubbe HD, Van Aken H, Baba HA, Jahn UR, Brodner G, August C, Erren M, Booke M. Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia. Crit Care Med. 2003;3:903–909. doi: 10.1097/01.CCM.0000050289.15988.67.
    1. Poloujadoff MP, Borron SW, Amathieu R, Favret F, Camara MS, Lapostolle F, Vicaut E, Adnet F. Improved survival after resuscitation with norepinephrine in a murine model of uncontrolled hemorrhagic shock. Anesthesiology. 2007;3:591–596. doi: 10.1097/01.anes.0000281926.54940.6a.
    1. Hakstian RW, Hampson LG, Gurd FN. Pharmacological agents in experimental hemorrhagic shock. A controlled comparison of treatment with hydralazine, hydrocortisone, and levarterenol (1-norepinephrine) Arch Surg. 1961;3:335–347. doi: 10.1001/archsurg.1961.01300150009002.
    1. Meier J, Pape A, Loniewska D, Lauscher P, Kertscho H, Zwissler B, Habler O. Norepinephrine increases tolerance to acute anemia. Crit Care Med. 2007;3:1484–1492. doi: 10.1097/01.CCM.0000265740.62130.1C.
    1. Alspaugh DM, Sartorelli K, Shackford SR, Okum EJ, Buckingham S, Osler T. Prehospital resuscitation with phenylephrine in uncontrolled hemorrhagic shock and brain injury. J Trauma. 2000;3:851–863. doi: 10.1097/00005373-200005000-00008. discussion 863–854.
    1. Feinstein AJ, Patel MB, Sanui M, Cohn SM, Majetschak M, Proctor KG. Resuscitation with pressors after traumatic brain injury. J Am Coll Surg. 2005;3:536–545. doi: 10.1016/j.jamcollsurg.2005.05.031.
    1. Sanui M, King DR, Feinstein AJ, Varon AJ, Cohn SM, Proctor KG. Effects of arginine vasopressin during resuscitation from hemorrhagic hypotension after traumatic brain injury. Crit Care Med. 2006;3:433–438. doi: 10.1097/01.CCM.0000196206.83534.39.
    1. Steiner LA, Johnston AJ, Czosnyka M, Chatfield DA, Salvador R, Coles JP, Gupta AK, Pickard JD, Menon DK. Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured patients. Crit Care Med. 2004;3:1049–1054. doi: 10.1097/01.CCM.0000120054.32845.A6.
    1. Pfister D, Strebel SP, Steiner LA. Effects of catecholamines on cerebral blood vessels in patients with traumatic brain injury. Eur J Anaesthesiol Suppl. 2008;3:98–103.
    1. Cavus E, Meybohm P, Dorges V, Stadlbauer KH, Wenzel V, Weiss H, Scholz J, Bein B. Regional and local brain oxygenation during hemorrhagic shock: a prospective experimental study on the effects of small-volume resuscitation with norepinephrine. J Trauma. 2008;3:641–648. doi: 10.1097/TA.0b013e3181637a6c. discussion 648–649.
    1. Johnson KB, Pearce FJ, Jeffreys N, McJames SW, Cluff M. Impact of vasopressin on hemodynamic and metabolic function in the decompensatory phase of hemorrhagic shock. J Cardiothorac Vasc Anesth. 2006;3:167–172. doi: 10.1053/j.jvca.2005.11.015.
    1. Stadlbauer KH, Wagner-Berger HG, Raedler C, Voelckel WG, Wenzel V, Krismer AC, Klima G, Rheinberger K, Nussbaumer W, Pressmar D. Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology. 2003;3:699–704. doi: 10.1097/00000542-200303000-00018.
    1. Voelckel WG, Raedler C, Wenzel V, Lindner KH, Krismer AC, Schmittinger CA, Herff H, Rheinberger K, Konigsrainer A. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med. 2003;3:1160–1165. doi: 10.1097/01.CCM.0000060014.75282.69.
    1. Raedler C, Voelckel WG, Wenzel V, Krismer AC, Schmittinger CA, Herff H, Mayr VD, Stadlbauer KH, Lindner KH, Konigsrainer A. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesth Analg. 2004;3:1759–1766. table of contents.
    1. Stadlbauer KH, Wagner-Berger HG, Krismer AC, Voelckel WG, Konigsrainer A, Lindner KH, Wenzel V. Vasopressin improves survival in a porcine model of abdominal vascular injury. Crit Care. 2007;3:R81. doi: 10.1186/cc5977.
    1. Meybohm P, Cavus E, Dorges V, Weber B, Stadlbauer KH, Wenzel V, Scholz J, Steffen M, Bein B. Release of protein S100B in haemorrhagic shock: effects of small volume resuscitation combined with arginine vasopressin. Resuscitation. 2008;3:449–456. doi: 10.1016/j.resuscitation.2007.09.002.
    1. Sperry JL, Minei JP, Frankel HL, West MA, Harbrecht BG, Moore EE, Maier RV, Nirula R. Early use of vasopressors after injury: caution before constriction. J Trauma. 2008;3:9–14. doi: 10.1097/TA.0b013e31815dd029.
    1. Plurad DS, Talving P, Lam L, Inaba K, Green D, Demetriades D. Early vasopressor use in critical injury is associated with mortality independent from volume status. J Trauma. 2011;3:565–570. doi: 10.1097/TA.0b013e3182213d52. discussion 570–562.
    1. Cohn SM, McCarthy J, Stewart RM, Jonas RB, Dent DL, Michalek JE. Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg. 2011;3:430–439. doi: 10.1007/s00268-010-0875-8.
    1. Harrois A, Duranteau J. In: Réanimation médicale. Offenstadt G, editor. Issy les Moulineaux: Elsevier Masson; 2009. Etats de choc: choc hémorragique; pp. 778–785.
    1. Santelli D, Garnier F, Menton C. In: Principes de réanimation chirurgicale. J.-L. P, C M, editor. Rueil Malmaison: Arnette; 2005. Choc hémorragique; pp. 426–436.
    1. Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;3:1105–1109. doi: 10.1056/NEJM199410273311701.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren